Manager strategy

PE firms continue to vie for assets in the increasingly digitalised healthcare market, but a selective approach is critical if they are to navigate challenges such as regulation and intense competition.

With so many funds in market chasing ever-heightening targets, GPs cannot rely solely on their returns track record to secure LP commitments.

Follow-on funds are the latest proof that buying, holding and selling within five years is largely a thing of the past.

Highlights from KKR's 2021 sustainability report, including: thoughts from its sustainability advisory council; its three 'Global Ambitions'; and the credit team's coming framework for sustainability-linked loans.

GPs often underestimate the effort and expertise required to service their management companies, but with the right resources, they can stay in the good graces of regulators and focus on delivering returns.

Leon is among a handful of first-timers moving into the tough fundraising environment favouring existing relationships and established funds over newcomers.

Inflationary pressure has been driven by different factors relative to previous iterations of rate hikes, Edwin Conway, global head of BlackRock Alternative Investors tells PEI.

KKR’s co-heads of Europe, Philipp Freise and Mattia Caprioli, discuss investing during wartime, and doubling down on their partnership playbook for Europe.

Dedicated life sciences firms with strong AUM growth have been prime targets for larger GPs recently – here's a list of firms ranked by capital raised.

Favourable conditions are spurring the country’s private equity industry into the next stage of development, say NSSK’s Jun Tsusaka and Shohei Akiyama.